Tempus
PROVIDERS
LIFE SCIENCES
PATIENTS
OUR PLATFORM
ORDER A TEST
Log In
Contact Us
Menu
Tempus
ORDER A TEST
Log In
Contact Us
Providers
Oncology
Neurology & Psychiatry
Infectious Disease
Cardiology
Academic & Research
EMR Integration
Life Sciences
Sequencing
Companion Diagnostics
Clinical Trial Solutions
Data Collaborations
AI Applications
Biological Modeling
Patients
Oncology Patients
Neurology Patients
Infectious Disease Patients
Our Platform
Genomic Profiling
Clinical Trial Matching
Companion Diagnostics
Multi-Omics
Tempus ONE
Infectious Disease
About Us
Our Team
Careers
Culture
Resources
Publications
News
Blog
Resources
Publications
Keyword search
Filter By
Oncology
Infectious Disease
Cardiology
Neuro/Psych
12/01/2020
Oncology
Spatial and Temporal Heterogeneity of PD-L1 Expression and Tumor Mutational Burden in Gastroesophageal Adenocarcinoma at Baseline Diagnosis and after Chemotherapy
11/12/2020
Cardiology
Prediction of Incident AF With Deep Learning Can Identify Patients at High Risk for AF-related Stroke
11/01/2020
Oncology
Safety and Efficacy of a Randomized Phase I Trial to Evaluate Concurrent or Sequential Ipilimumab, Nivolumab, and Stereotactic Body Radiotherapy in Patients with Stage IV Non-small Cell Lung Cancer (COSINR Study)
10/19/2020
Oncology
Targeted Next-Generation Sequencing (NGS) of 105 Cancer-Related Genes in Circulating Tumor DNA (ctDNA) From Patients With Advanced Cancers Treated With Immune Checkpoint Inhibitors (iCPI)
10/02/2020
Oncology
Complete Response in a Patient With Chemorefractory EGFR-Amplified, PD-L1–Positive Metastatic Gastric Cancer Treated By Dual Anti-EGFR and Anti–PD-1 Monoclonal Antibody Therapy
07/17/2020
Oncology
Global Activation of Oncogenic Pathways Underlies Therapy Resistance in Diffuse Midline Glioma
06/11/2020
Oncology
Molecular Analysis of Atypical Deep Penetrating Nevus Progressing to Melanoma
06/03/2020
Oncology
Development and Characterization of Patient-Derived Xenografts from Non-Small Cell Lung Cancer Brain Metastases
05/15/2020
Oncology
Recurrent Transcriptionally Active ESR1 Fusions Render Therapeutic Vulnerabilities to Kinase Inhibition in Advanced Breast Cancer
05/15/2020
Oncology
Accurate Estimation of Circulating Tumor DNA Fraction From Ultra Low-pass Whole-genome Sequencing
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21